Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine - PubMed (original) (raw)
Review
. 2014 Jul 8;64(1):83-99.
doi: 10.1016/j.jacc.2014.05.003.
Affiliations
- PMID: 24998133
- DOI: 10.1016/j.jacc.2014.05.003
Free article
Review
Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine
Barry J Maron et al. J Am Coll Cardiol. 2014.
Free article
Erratum in
- J Am Coll Cardiol. 2014 Sep 16;64(11):1188
Abstract
Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with diverse phenotypic and genetic expression, clinical presentation, and natural history. HCM has been recognized for 55 years, but recently substantial advances in diagnosis and treatment options have evolved, as well as increased recognition of the disease in clinical practice. Nevertheless, most genetically and clinically affected individuals probably remain undiagnosed, largely free from disease-related complications, although HCM may progress along 1 or more of its major disease pathways (i.e., arrhythmic sudden death risk; progressive heart failure [HF] due to dynamic left ventricular [LV] outflow obstruction or due to systolic dysfunction in the absence of obstruction; or atrial fibrillation with risk of stroke). Effective treatments are available for each adverse HCM complication, including implantable cardioverter-defibrillators (ICDs) for sudden death prevention, heart transplantation for end-stage failure, surgical myectomy (or selectively, alcohol septal ablation) to alleviate HF symptoms by abolishing outflow obstruction, and catheter-based procedures to control atrial fibrillation. These and other strategies have now resulted in a low disease-related mortality rate of <1%/year. Therefore, HCM has emerged from an era of misunderstanding, stigma, and pessimism, experiencing vast changes in its clinical profile, and acquiring an effective and diverse management armamentarium. These advances have changed its natural history, with prevention of sudden death and reversal of HF, thereby restoring quality of life with extended (if not normal) longevity for most patients, and transforming HCM into a contemporary treatable cardiovascular disease.
Keywords: atrial fibrillation; cardiac surgery; echocardiography; genetics; heart failure; hypertrophic cardiomyopathy; implantable defibrillators; magnetic resonance imaging; sudden death.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
- Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more?
Jan MF, Tajik AJ. Jan MF, et al. J Am Coll Cardiol. 2014 Dec 16;64(23):2560-2. doi: 10.1016/j.jacc.2014.09.043. J Am Coll Cardiol. 2014. PMID: 25500246 No abstract available. - Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more?
Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Maron BJ, et al. J Am Coll Cardiol. 2014 Dec 16;64(23):2562. doi: 10.1016/j.jacc.2014.10.001. J Am Coll Cardiol. 2014. PMID: 25500247 No abstract available.
Similar articles
- [Hypertrophic cardiomyopathy: current aspects and new developments].
Desnos M. Desnos M. Bull Acad Natl Med. 2012 Apr-May;196(4-5):997-1009; discussion 1009-10. Bull Acad Natl Med. 2012. PMID: 23550458 French. - Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS. Maron BJ, et al. J Am Coll Cardiol. 2015 May 12;65(18):1915-28. doi: 10.1016/j.jacc.2015.02.061. J Am Coll Cardiol. 2015. PMID: 25953744 - Hypertrophic cardiomyopathy.
Maron BJ, Maron MS. Maron BJ, et al. Lancet. 2013 Jan 19;381(9862):242-55. doi: 10.1016/S0140-6736(12)60397-3. Epub 2012 Aug 6. Lancet. 2013. PMID: 22874472 Review. - Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ, Rowin EJ, Casey SA, Lesser JR, Garberich RF, McGriff DM, Maron MS. Maron BJ, et al. Circulation. 2016 Jan 5;133(1):62-73. doi: 10.1161/CIRCULATIONAHA.115.017633. Epub 2015 Oct 30. Circulation. 2016. PMID: 26518766 - The 20 advances that have defined contemporary hypertrophic cardiomyopathy.
Maron BJ, Maron MS. Maron BJ, et al. Trends Cardiovasc Med. 2015 Jan;25(1):54-64. doi: 10.1016/j.tcm.2014.09.004. Trends Cardiovasc Med. 2015. PMID: 25446045 Review.
Cited by
- Exercise in Hypertrophic Cardiomyopathy: Recent Conceptual Changes and Recommendations for Pre-Exercise Tests.
Seo J, Choi EY, Rim SJ. Seo J, et al. Rev Cardiovasc Med. 2023 Jun 6;24(6):166. doi: 10.31083/j.rcm2406166. eCollection 2023 Jun. Rev Cardiovasc Med. 2023. PMID: 39077517 Free PMC article. Review. - High prevalence of ALPK3 premature terminating variants in Korean hypertrophic cardiomyopathy patients.
Ryu SW, Jeong WC, Hong GR, Cho JS, Lee SY, Kim H, Jang JY, Lee SH, Bae DH, Cho JY, Kim JH, Kim KH, Son JW, Han B, Seo GH, Lee H. Ryu SW, et al. Front Cardiovasc Med. 2024 Jul 5;11:1424551. doi: 10.3389/fcvm.2024.1424551. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39036505 Free PMC article. - Hypertrophic Cardiomyopathy: From Medical Treatment to Advanced Heart Failure Therapies.
Mazur M, Braksator W, Popjes E. Mazur M, et al. Curr Cardiol Rep. 2024 Sep;26(9):985-994. doi: 10.1007/s11886-024-02095-6. Epub 2024 Jul 11. Curr Cardiol Rep. 2024. PMID: 38990491 Review. - Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy.
Zhi Y, Gui FD, Xue M, Long YT, Miao W, Yi Y, Gao LC, Bing F, Pan SY. Zhi Y, et al. BMC Cardiovasc Disord. 2024 Apr 9;24(1):203. doi: 10.1186/s12872-024-03859-2. BMC Cardiovasc Disord. 2024. PMID: 38594610 Free PMC article. - Hypertrophic cardiomyopathy in MYBPC3 carriers in aging.
Ananthamohan K, Stelzer JE, Sadayappan S. Ananthamohan K, et al. J Cardiovasc Aging. 2024 Jan;4(1):9. doi: 10.20517/jca.2023.29. Epub 2024 Jan 11. J Cardiovasc Aging. 2024. PMID: 38406555 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous